CV Sciences Inc (CVSI)

[jefra1965]

Don't forget the BIG possibility of raising some cash along the way.

For example: To raise $120M some time next year will cost the company 4.8M shares only. A dilution of 3.5- 4.5% THEN. Compare that to other CBD competitors that have raised money recently. CWEB, ELLXF and ISOLD.

And the company doesn't want nor need any CASH raise right now. The management team i very smart, I'm sure they are looking forward to this situation. That's why they haven't sold a single share YTD. They will be able to cash in just a small part of their holdings next year and still keep the bulk for when the stock really appreciate above $75-$100.
CVSI is performing in the 25%++ range of FCF. CVSI is going to make $22M+ of FCF next year EASY. The current TTM FCF rate is $8.14M out of $33.25M which comes to TTM FCF = 24.48% And improving fast.

This are facts about the actual trends.

Just an example:HIGHLIGHTS:

• A$40 million institutional placement
• Majority of funds raised to be applied to facilitate the acceleration of Elixinol Global’s USA and
European growth initiatives
Elixinol Global Limited (Elixinol Global, Group or the Company) (ASX: EXL; OTCQX: ELLXF), a global company operating in the industrial hemp, dietary supplements and emerging medicinal cannabis sectors, is pleased to announce that it has successfully completed a placement to domestic and international institutional and sophisticated investors raising A$40 million at A$1.85 per share (Placement), representing a 3.3% discount to the 15 day Volume Weighted Average Price (VWAP) of $1.91.
Elixinol Global Chief Executive Officer, Mr Paul Benhaim, said: “The global cannabis market is growing at a rapid rate and Elixinol Global recognises the need to move quickly to leverage the opportunity around the business. This funding ensures we can seize the market opportunities in front of us, and in doing so, propel the business toward its next phase of growth.
Placement
The Company’s fully paid ordinary shares (“Placement Shares”) were offered at $1.85 per share, representing a 14.0% discount to the last closing price of $2.15 and a 3.3% discount to the 15 day Volume Weighted Average Price (VWAP) of $1.91. The Placement represents approximately 21.0% of the Company’s issued capital and was conducted under the 15% placement capacity of the Company in accordance with ASX LR 7.1 and additional 10% placement capacity of the Company in accordance with ASX LR 7.1A. As such, no shareholder approval was required.
Existing ordinary shares on issue pre-Placement Placement ordinary shares issued
Ordinary shares on issue post-Placement
102,928,540
21,621,622
124,550,162

ELLX$
AUD/USD was 0.73 for this transaction.
A dilution of 21% for $29.2 USD

This company sold $7+M USD last quarter and just turned profitable and is trending nicely which is very good, but in comparison CVSI is the Big Kahuna of CBD. The same happens with all competitors. CVSI's efficiency is unmatched.

https://backend.otcmarkets.com/otcapi/company/dns/news/document/33501/content